Skip to main content
. 2023 Nov 27;15(23):5597. doi: 10.3390/cancers15235597
C chemotherapy
CMTM6 CKLF-like MARVEL transmembrane domain 6
CPS combined positive score
d day
HNSCC head and neck squamous cell carcinoma
HPV human papillomavirus
PD-L1 programmed death-ligand 1
ICI immune checkpoint inhibitors
OS overall survival
PFS progression-free survival
py pack years
RCT radio-chemotherapy
RT radiotherapy
r/m recurrent and/or metastatic
TIGIT T cell immunoglobulin and ITIM domain